exa-cel
vertex pharmaceuticals,CRISPR Therapeutics AG
['exa-cel', 'exagamglogene']
vertex and crispr therapeutics present new data on more patients with longer follow-up treated with exagamglogene autotemcel (exa-cel) at the 2022 european hematology association (eha) congress 
World's largest global Connected Community(tm) focused on HEOR, RWE and Market Access. Digital Channel owned by https://t.co/ZmJWTEwfNA.